FindTrial
Sign In

A clinical study to compare the incidence of Urinary Tract Infection between metal coated urinary catheter and conventional latex urinary catheter in ICU patients

Incidence of bacterial and fungal Urinary Tract Infection with metal alloy impregnated urinary catheter (BIP foley catheter) in comparison to conventional latex foley catheter in ICU- a prospective interventional study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021306
Enrollment
200
Registered
2019-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Metal alloy impregnated urinary catheter (Silver, Gold and palladium alloy) (BIP Foley catheter): All adult patients fulfilling inclusion criteria with any critical illness, requiring u

Sponsors

Dr BADRI PRASAD DAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients( >18 years and Admitted with any critical illness No UTI Requiring a urinary catheter for atleast 3 days Using a closed drainage system Will be included in the study

Exclusion criteria

Exclusion criteria: Children Patients with UTI Known case if BPH Patients using open drainage system Any congenital urinary tract abnormalities or obstetrics/gyanaecological abnormalities Patients with duration of catheter Diabetic patients Will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Incidence of nosocomial urinary tract infection both bacterial and fungal including frequency of symptomatic catheter associated urinary tract infection and catheter associated asymptomatic bacteriuriaTimepoint: after 3 days of onset of fever or earlier if fever occurs and at every onset of fever—

Secondary

MeasureTime frame
To assess safety and cost effectiveness clinical outcome in form of 30 days mortalityTimepoint: Till 30 days or earlier when it needs to be removed due to blockage or patient dies or patient is shifted to ward—

Countries

India

Contacts

Public ContactDr Munesh Kumar Gupta

IMS BHU

priyasingla.3192@gmail.com9999729484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026